評論
打印
"Overnight, we went from taking out children's eyes to not taking out children's eyes."
“一夜之間，孩子的眼睛得以保留。”
OAC is now performed in 45 countries, where it allows doctors to save 95 percent of eyes afflicted with retinoblastoma.
如今，眼科動脈化療技術(shù)(OAC)在45個國家投入使用，95%患有視網(wǎng)膜母細胞瘤的眼睛得以治療。
But there's an aspect of OAC that Dr. Abramson doesn't talk about much, even though it is as inspirational as the technique itself.
但對于該技術(shù)的另一方面，艾布拉姆森醫(yī)生并沒有談?wù)撎啵M管它和技術(shù)本身一樣鼓舞人心。
He won't make a dime off OAC, because he refused to patent it.
因為艾布拉姆森拒絕申請專利，所以他不會從中賺取利潤。
Pursuing a patent, he feared, would have meant keeping the technique under wraps for a long period of time
他擔心申請專利意味著很長一段時間內(nèi)對技術(shù)保密，
while the paperwork was approved by the U.S. Trademark and Patent Office.
而文書得到了美國商標和專利局的批準。
In the meantime, untold numbers of children would have suffered and perhaps died.
與此同時，不計其數(shù)的兒童深受其害，甚至可能面臨死亡。
Patent experts wouldn't venture a guess on exactly how much money Dr. Abramson left on the table by not patenting his procedure.
專利專家不會冒險猜測艾布拉姆森醫(yī)生不申請專利的話到底還剩多少錢，
But, says Devon Herrick, a health-care economist at the National Center for Policy Analysis,
但是，國家政策分析中心的醫(yī)療經(jīng)濟學(xué)家德文·赫里克說，
"the purpose of a medical procedure patent is that it allows a doctor to profit by teaching others to perform the procedure."
“設(shè)置醫(yī)療程序?qū)＠哪康脑谟卺t(yī)生可以通過教別人做手術(shù)來盈利。”
By not patenting, Dr. Abramson chose to forgo those profits.
艾布拉姆森醫(yī)生不申請專利，他選擇放棄利潤。
"I want people to know that when I endorse something, it's from my scientific heart, not because I had any financial benefit," he says.
他說：“我希望人們知道，當我支持某件事時，是出于科學(xué)考慮，而不是因為任何的經(jīng)濟利益。”
"And ultimately, our goal was to help children. Our driving force in this was not to make money."
“我們的最終目標是幫助兒童，不是為了賺錢。”
